SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote ()3/15/1999 1:08:00 AM
From: Bob L   of 1762
 
Table 3. Response to Therapy

Response
CR PR CR + PR
Patient Group No. No. % No. % No. %

Intent-to-treat 40 22 55 16 40 38 95
Extranodal disease 29 15 52 14 48 29 100
Elevated LDH 11 5 45 6 55 11 100
Bone marrow involvement 22 11 50 11 50 22 100
Age @ 60 years 11 5 45 6 55 11 100
Bulky disease* 14 4 29 10 71 14 100

Abbreviation: LDH, lactate dehydrogenase.
*Patients who had a lesion measuring at least 5 cm (but no more than 10 cm) in the largest diameter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News